Hormone replacement therapy and prognosis in ovarian cancer patients.
about
Metabolomic profiling unravels DNA adducts in human breast that are formed from peroxidase mediated activation of estrogens to quinone methidesEstrogen biosynthesis and action in ovarian cancer.Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study.Endometriosis as a risk factor for ovarian or endometrial cancer - results of a hospital-based case-control study.Menopausal hormone therapy and mortality among women diagnosed with ovarian cancer in the NIH-AARP Diet and Health Study.WAP four-disulfide core domain protein 2 gene(WFDC2) is a target of estrogen in ovarian cancer cellsRole of Nerve Growth Factor (NGF) and miRNAs in Epithelial Ovarian Cancer.The Role of Endocrine G Protein-Coupled Receptors in Ovarian Cancer Progression.The safety of postoperative hormone replacement therapy in epithelial ovarian cancer patients in China.Hypnotherapy to Reduce Hot Flashes: Examination of Response Expectancies as a Mediator of Outcomes.Reproductive and hormonal factors in relation to survival and platinum resistance among ovarian cancer cases.
P2860
Q28533703-E50025FC-A975-4055-A642-E9075F4E559CQ34496401-10E5D93D-A530-4D49-8C1E-C8AE5E9EC334Q34687073-83D70497-F181-492F-8D9B-2C14F3171390Q35815412-6F9CCB31-71FF-48F1-9398-F8E2F5BB138AQ36039829-78A34140-F47B-42D9-B406-66629763FBB8Q36629304-1501896D-6285-44EE-A838-F9735F05EF39Q37729033-9B33E88D-55CC-4E2A-8B38-11486400B3DAQ37740526-ECD2FBEE-3706-446B-9A22-EDB2E6577A9EQ38109644-980C95D5-4D8B-4679-90AF-A4F828BD25ABQ38681365-CAA61875-24FB-449A-8F84-599A85BE0D80Q39324480-384DAD88-E40F-47C1-84F6-464B4A6A68E8
P2860
Hormone replacement therapy and prognosis in ovarian cancer patients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Hormone replacement therapy and prognosis in ovarian cancer patients.
@en
Hormone replacement therapy and prognosis in ovarian cancer patients.
@nl
type
label
Hormone replacement therapy and prognosis in ovarian cancer patients.
@en
Hormone replacement therapy and prognosis in ovarian cancer patients.
@nl
prefLabel
Hormone replacement therapy and prognosis in ovarian cancer patients.
@en
Hormone replacement therapy and prognosis in ovarian cancer patients.
@nl
P2093
P50
P1476
Hormone replacement therapy and prognosis in ovarian cancer patients.
@en
P2093
Andreas Müller
Arndt Hartmann
Christian M Bayer
Claudia Rauh
David Wachter
Falk C Thiel
Johanna Strehl
Lothar Häberle
Michael G Schrauder
Sebastian M Jud
P356
10.1097/CEJ.0B013E328355EC22
P407
P577
2013-01-01T00:00:00Z